Pins and Needles on Semaglutide: What's Causing It and When to Act

Pins and needles on semaglutide is usually linked to temporary changes in blood sugar regulation, posture habits during injections, or peripheral nerve sensitivity — not a sign the medicine is harming your nerves.
Most cases settle on their own within days; persistent, worsening or one-sided tingling always warrants a call to your prescriber or GP.
People with type 2 diabetes starting semaglutide may notice tingling as blood-sugar levels shift, a known early phenomenon, not a cause for alarm on its own.
Staying well hydrated and eating enough protein during treatment supports nerve health; GI side effects that reduce intake can be a contributing factor.

Pins and needles is an occasional side effect reported by people taking semaglutide (Wegovy), most often felt in the hands, feet or legs. It is not listed among the most common effects, but it does come up — and understanding why helps you decide whether to wait it out or speak to your prescriber. Semaglutide is a prescription-only medicine; any new or persistent symptom should be discussed with a clinician who knows your full picture.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How to tell what's driving the tingling, and what to do next

Step 1, Work out when the tingling started and where it sits

The first useful step is pinning down the pattern. Did the pins and needles begin shortly after your first injection or after a dose increase? Is it symmetrical (both hands, both feet) or only on one side? Does it come and go, or stay for hours? These details matter, because semaglutide-related tingling and tingling from an unrelated cause look different in practice.

Wegovy works as a GLP-1 receptor agonist, slowing gastric emptying and influencing how the body handles glucose. When someone's blood-sugar levels fall more smoothly (particularly early in treatment) peripheral nerves can respond with transient tingling. The NHS semaglutide medicines page describes a range of nervous-system effects that have been reported, including dizziness and headache, and temporary tingling sits in a similar category: a signalling blip, not structural nerve damage.

If you are living with type 2 diabetes, the picture needs an extra layer of scrutiny. Improved glycaemic control after starting a GLP-1 medicine can occasionally produce transient tingling in people who already have some degree of peripheral neuropathy. This is a reason to keep your prescriber informed, not a reason to stop treatment on your own initiative. Changes to your treatment should always follow clinical advice, including adjustments to dose or timing.

Step 2, Check whether injection technique or positioning is a factor

A question our prescribers hear most weeks is whether the injection itself could be causing the tingling. The short answer: possibly, yes, in a limited and localised way. If you inject repeatedly into the same spot (the same square centimetre of abdomen or thigh) you can develop small areas of lipohypertrophy (fatty thickening under the skin), and injecting into these can affect local nerve sensation. Rotating injection sites addresses this directly.

Posture during and after injection is worth considering too. Sitting in a fixed position with a pen pressed against your thigh, or tensing the muscle, can compress superficial nerves transiently. Our guidance on how to insert your Wegovy pen covers technique in full, including site rotation and the importance of relaxing the muscle before you inject. Getting technique right is rarely talked about in relation to tingling, but it genuinely makes a difference for some people.

Needle depth is another variable. Semaglutide is injected subcutaneously, into the fatty tissue just beneath the skin, not the muscle. If the needle goes deeper than intended, the sensation can be sharper and can occasionally leave a tingling residue. Detail on the right needle size for semaglutide is worth checking if you have any doubt about your current setup. Keeping the injection site clean before each dose and using a fresh needle every time also reduces localised irritation.

Step 3, Know when tingling crosses into something to act on promptly

Most semaglutide-related pins and needles is mild, symmetrical and self-limiting. The situations that call for prompt medical attention are different in character: tingling that is one-sided or appears suddenly alongside other new symptoms (facial drooping, arm weakness, speech changes) needs emergency assessment, as these are warning signs unrelated to semaglutide itself. Similarly, tingling combined with severe persistent stomach pain that radiates to the back may point to pancreatitis, which the MHRA Drug Safety Update programme has highlighted as an infrequent but serious risk with GLP-1 medicines, seek urgent help rather than waiting.

If the tingling is milder but keeps spreading, worsens at each dose increase, or is accompanied by muscle weakness, book a call with your prescriber rather than managing it alone. They can assess whether a slower titration, a temporary hold, or simply monitoring is the right call. Tingling that has an obvious trigger (eating too little, dehydration from nausea) often improves with simple changes that your prescriber can help you plan. Explore the broader Wegovy treatment guide for context on managing side effects during dose escalation.

Step 4, Practical support for ongoing treatment

Outside the acute question of what the tingling is, there are a few practical things that help. Adequate protein intake is the most commonly underappreciated factor; GLP-1 medicines reduce appetite substantially, and people who eat very little can inadvertently reduce their vitamin B12 and B-group intake, both of which are relevant to nerve function. Staying hydrated matters too, nausea and vomiting in the early weeks can quietly tip someone into mild dehydration, which amplifies peripheral nerve sensitivity.

If you are considering Wegovy and want to understand what the injection process actually involves, the guide to needles for Wegovy gives a clear overview, including what comes with the pen and what you might want in addition. For those already on treatment through a private prescriber elsewhere, our private Wegovy service includes clinical review at each step, every repeat prescription is assessed individually, so symptoms like persistent tingling are part of that conversation, not an afterthought. Weight-loss injections are a broad category; understanding how different GLP-1 medicines compare can help frame your options if semaglutide is not suiting you well.

If you have not yet started treatment and want a clinician to weigh up your full picture before you do, checking your eligibility is the right first step. See our treatment options page to begin your free consultation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions